LOHR, Frank Reinhard Heinrich
 Distribuzione geografica
Continente #
NA - Nord America 30.046
AS - Asia 9.584
EU - Europa 7.969
SA - Sud America 1.632
Continente sconosciuto - Info sul continente non disponibili 723
AF - Africa 199
OC - Oceania 35
Totale 50.188
Nazione #
US - Stati Uniti d'America 29.357
SG - Singapore 2.636
GB - Regno Unito 1.805
HK - Hong Kong 1.770
CN - Cina 1.761
IT - Italia 1.378
BR - Brasile 1.242
FI - Finlandia 1.110
SE - Svezia 1.071
VN - Vietnam 1.051
DE - Germania 882
BD - Bangladesh 794
TR - Turchia 568
RU - Federazione Russa 408
FR - Francia 295
CA - Canada 284
UA - Ucraina 255
BG - Bulgaria 233
IN - India 179
AR - Argentina 149
ID - Indonesia 136
BZ - Belize 122
KR - Corea 121
JP - Giappone 101
MX - Messico 97
NL - Olanda 88
IQ - Iraq 76
AE - Emirati Arabi Uniti 71
IE - Irlanda 66
ZA - Sudafrica 61
ES - Italia 59
CO - Colombia 54
EC - Ecuador 52
MY - Malesia 49
PL - Polonia 49
PK - Pakistan 48
AT - Austria 45
BE - Belgio 44
CL - Cile 41
VE - Venezuela 41
SA - Arabia Saudita 36
CZ - Repubblica Ceca 34
CR - Costa Rica 33
AU - Australia 26
MA - Marocco 24
PH - Filippine 24
EG - Egitto 23
LT - Lituania 23
PY - Paraguay 23
HN - Honduras 21
UZ - Uzbekistan 21
JM - Giamaica 20
JO - Giordania 18
DZ - Algeria 17
KE - Kenya 17
RO - Romania 17
CH - Svizzera 16
DO - Repubblica Dominicana 15
PE - Perù 15
PR - Porto Rico 15
SV - El Salvador 15
NI - Nicaragua 14
TH - Thailandia 14
TN - Tunisia 14
TT - Trinidad e Tobago 14
NP - Nepal 13
PT - Portogallo 13
AZ - Azerbaigian 12
GT - Guatemala 11
IL - Israele 11
TW - Taiwan 10
BY - Bielorussia 9
DK - Danimarca 9
KZ - Kazakistan 9
EE - Estonia 8
SI - Slovenia 8
BO - Bolivia 7
GR - Grecia 7
AL - Albania 6
BH - Bahrain 6
IR - Iran 6
NZ - Nuova Zelanda 6
QA - Qatar 6
RS - Serbia 6
SN - Senegal 6
XK - ???statistics.table.value.countryCode.XK??? 6
BB - Barbados 5
HU - Ungheria 5
LB - Libano 5
NO - Norvegia 5
PA - Panama 5
SY - Repubblica araba siriana 5
TG - Togo 5
CI - Costa d'Avorio 4
CY - Cipro 4
ET - Etiopia 4
MD - Moldavia 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
Totale 49.394
Città #
Fairfield 3.531
Ashburn 3.428
Santa Clara 2.024
Singapore 1.890
Hong Kong 1.746
Houston 1.598
Woodbridge 1.546
Chandler 1.456
Seattle 1.395
Cambridge 1.177
San Jose 1.118
Wilmington 1.099
Helsinki 1.083
Southend 898
Council Bluffs 799
Dearborn 717
London 626
Nyköping 531
Ann Arbor 528
Izmir 376
Jacksonville 371
Beijing 349
Ho Chi Minh City 323
The Dalles 307
San Diego 303
Los Angeles 299
Princeton 251
New York 237
Buffalo 234
Hanoi 229
Sofia 222
Modena 215
Boardman 200
Chicago 200
Eugene 195
Milan 191
Lauterbourg 174
Istanbul 146
Dallas 145
Las Vegas 143
Hefei 136
São Paulo 133
Moscow 128
Bremen 127
Columbus 126
Belize City 122
Shanghai 114
Seoul 112
Albuquerque 104
Munich 102
Redondo Beach 99
Jakarta 88
Rome 86
Saint Augustine 86
Tokyo 81
Saint Louis 77
Frankfurt am Main 69
Atlanta 63
Salt Lake City 57
Dublin 55
Phoenix 55
Toronto 52
Orem 51
San Francisco 47
Brooklyn 46
Falls Church 46
Warsaw 45
Denver 44
Miano 44
Montreal 44
Boston 42
Haiphong 42
Naples 42
Dong Ket 41
Kunming 41
Da Nang 39
Brussels 38
Guangzhou 37
Washington 37
Nuremberg 35
Norwalk 34
Chennai 33
Raleigh 32
Bologna 30
Baghdad 29
Brasília 29
Johannesburg 29
Mexico City 29
Nanjing 29
Tampa 29
Amsterdam 28
Rio de Janeiro 28
Elk Grove Village 26
Miami 26
Paris 26
Norfolk 25
North Bergen 25
Belo Horizonte 24
Charlotte 24
Stockholm 24
Totale 35.692
Nome #
Deep Inspiration Breath Hold-Based Radiation Therapy: A Clinical Review 573
Simulation of 3D-treatment plans in head and neck tumors aided by matching of digitally reconstructed radiographs (DRR) and on-line distortion corrected simulator images 409
Pros-IT CNR: an Italian prostate cancer monitoring project 366
Sequential chemo-hypofractionated RT versus concurrent standard CRT for locally advanced NSCLC: GRADE recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 338
Optimized Volumetric Modulated Arc Therapy Versus 3D-CRT for Early Stage Mediastinal Hodgkin Lymphoma Without Axillary Involvement: A Comparison of Second Cancers and Heart Disease Risk 332
Assessment of neuropsychological changes in patients with arteriovenous malformation (AVM) after radiosurgery 329
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 314
Adjuvant IMRT/XELOX radiochemotherapy improves long-term overall- and disease-free survival in advanced gastric cancer 307
Expert system classifier for adaptive radiation therapy in prostate cancer 307
A new strategy for online adaptive prostate radiotherapy based on cone-beam CT 305
A comparison of several modulated radiotherapy techniques for head and neck cancer and dosimetric validation of VMAT 305
Adjuvant therapy in resectable gastric cancer—the CRITICS trial 303
Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer 302
A fast radiotherapy paradigm for anal cancer with volumetric modulated arc therapy (VMAT) 301
A machine learning tool for re-planning and adaptive RT: A multicenter cohort investigation 298
ACCURACY OF ULTRASOUND-BASED IMAGE GUIDANCE FOR DAILY POSITIONING OF THE UPPER ABDOMEN: AN ONLINE COMPARISON WITH CONE BEAM CT 294
A NOVEL DEVICE FOR INTRAVAGINAL ELECTRONIC BRACHYTHERAPY 293
Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis 292
Performance of an atlas-based autosegmentation software for delineation of target volumes for radiotherapy of breast and anorectal cancer 288
Phantom and in-vivo measurements of dose exposure by image-guided radiotherapy (IGRT): MV portal images vs. kV portal images vs. cone-beam CT 288
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: New evidence from a multicentric study 288
Accelerating total body irradiation with large field modulated arc therapy in standard treatment rooms without additional equipment 286
Hypofractionated image-guided breath-hold SABR (Stereotactic Ablative Body Radiotherapy) of liver metastases - clinical results 280
Accuracy of ultrasound-based (BAT) prostate-repositioning: A three-dimensional on-line fiducial-based assessment with cone-beam computed tomography 279
Acute central nervous system (CNS) toxicity of total body irradiation (TBI) measured using neuropsychological testing of attention functions 276
Cognitive function in patients with cerebral arteriovenous malformations after radiosurgery: Prospective long-term follow-up 276
Flattening filter free beams from TrueBeam and Versa HD units: Evaluation of the parameters for quality assurance 276
Migration patterns in pulsed-field electrophoresis of DNA restriction fragments from log-phase mammalian cells after irradiation and incubation for repair 273
Intrafraction motion of the prostate during an IMRT session: a fiducial-based 3D measurement with Cone-beam CT 271
Clinical outcome of hypofractionated breath-hold image-guided SABR of primary lung tumors and lung metastases 270
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer 269
Stereotactic single-dose radiation therapy of liver tumors: Results of a phase I/II trial 267
Fully automated, multi-criterial planning for Volumetric Modulated Arc Therapy – An international multi-center validation for prostate cancer 265
A multi-national report on stereotactic body radiotherapy for oligometastases: Patient selection and follow-up* 264
A novel lateral disequilibrium inclusive, (LDI) pencil-beam based dose calculation algorithm: Evaluation in inhomogeneous phantoms and comparison with Monte Carlo calculations 263
Predictive value of the flow cytometric PCNA assay (proliferating cell nuclear antigen) in head and neck tumors after accelerated-hyperfractionated radiochemotherapy 263
In-vivo treatment accuracy analysis of active motion-compensated liver SBRT through registration of plan dose to post-therapeutic MRI-morphologic alterations 263
Dose-escalated salvage radiotherapy after radical prostatectomy in high risk prostate cancer patients without hormone therapy: outcome, prognostic factors and late toxicity 263
A multinational report of technical factors on stereotactic body radiotherapy for oligometastases 262
Lethal pulmonary toxicity after autologous bone marrow transplantation peripheral blood stem cell transplantation for hematological malignancies 261
Adding Concomitant Chemotherapy to Postoperative Radiotherapy in Oral Cavity Carcinoma with Minor Risk Factors: Systematic Review of the Literature and Meta-Analysis 260
Reirradiation of Spinal Column Metastases Comparison of Several Treatment Techniques and Dosimetric Validation for the Use of VMAT 257
Differential sensitivity of three sublines of the rat dunning prostate tumor system R3327 to radiation and/or local tumor hyperthermia 256
Adjuvant treatment of brain metastases 256
Quantification and Assessment of Interfraction Setup Errors Based on Cone Beam CT and Determination of Safety Margins for Radiotherapy 256
Extracranial stereotactic radiation therapy: Set-up accuracy of patients treated for liver metastases 254
STEREOTACTIC, SINGLE-DOSE IRRADIATION OF LUNG TUMORS: A COMPARISON OF ABSOLUTE DOSE AND DOSE DISTRIBUTION BETWEEN PENCIL BEAM AND MONTE CARLO ALGORITHMS BASED ON ACTUAL PATIENT CT SCANS 252
OXYGEN-TENSION DISTRIBUTION IN HEAD AND NECK CARCINOMAS AFTER PERORAL OXYGEN-THERAPY 251
Fractionated stereotactic conformal radiation therapy of brain stem gliomas: outcome and prognostic factors 251
Cataract incidence after total-body irradiation 247
No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16 (INK4a) status 247
Radiotherapy for Early Mediastinal Hodgkin Lymphoma According to the German Hodgkin Study Group (GHSG): The Roles of Intensity-Modulated Radiotherapy and Involved-Node Radiotherapy 246
Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors 246
Evaluation of a 2D detector array for patient-specific VMAT QA with different setups 245
Radiotherapy for tumors of the stomach and gastroesophageal junction - a review of its role in multimodal therapy 244
Enhancement of radiotherapy by hyperthermia-regulated gene therapy 243
Neurobehavioral toxicity of total body irradiation: A follow-up in long-term survivors 242
Genital invasion or perigenital spread may pose a risk of marginal misses for Intensity Modulated Radiotherapy (IMRT) in anal cancer 242
Comparison of intensity-modulated radiotherapy with conventional conformal radiotherapy for complex-shaped tumors 242
"Freezing" the Tumor in a Known Position During Radiation Therapy In Regard to Boda-Heggemann et al 241
Influence of Institutional Experience and Technological Advances on Outcome of Stereotactic Body Radiation Therapy for Oligometastatic Lung Disease 241
Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study 241
COMBINED ADJUVANT RADIOCHEMOTHERAPY WITH IMRT/XELOX IMPROVES OUTCOME WITH LOW RENAL TOXICITY IN GASTRIC CANCER 240
Arc therapy for total body irradiation - A robust novel treatment technique for standard treatment rooms 240
A novel surface imaging system for patient positioning and surveillance during radiotherapy A phantom study and clinical evaluation 239
Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases 239
Prognostic Relevance of HPV Infection and p16 Overexpression in Squamous Cell Anal Cancer 239
Fully automated treatment planning of spinal metastases - A comparison to manual planning of Volumetric Modulated Arc Therapy for conventionally fractionated irradiation 239
Dose-dependent changes in renal H-1-/Na-23 MRI after adjuvant radiochemotherapy for gastric cancer 238
Long-term adjuvant administration of temozolomide in patients with glioblastoma multiforme: experience of a single institution 237
Flattening-filter-free intensity modulated breath-hold image-guided SABR (Stereotactic ABlative Radiotherapy) can be applied in a 15-min treatment slot 237
Review of potential improvements using MRI in the radiotherapy workflow 237
Frameless stereotactic radiosurgery of a solitary liver metastasis using active breathing control and stereotactic ultrasound 236
Improving dose homogeneity in large breasts by IMRT - Efficacy and dosimetric accuracy of different techniques 234
Image-guided radiation therapy 234
Patient-specific online dose verification based on transmission detector measurements 233
Development of a Geant4 based Monte Carlo Algorithm to evaluate the MONACO VMAT treatment accuracy 233
Comparison of anisotropic aperture based intensity modulated radiotherapy with 3D-conformal radiotherapy for the treatment of large lung tumors 233
Development of a neuro-fuzzy technique for automated parameter optimization of inverse treatment planning 233
Management of small bowel interferences in primary radiotherapy of prostate cancer 231
On the performances of different IMRT treatment planning systems for selected paediatric cases 231
Assessment of renal function after conformal radiotherapy and intensity-modulated radiotherapy by functional H-1-MRI and (23) Na-MRI 230
X-ray induced changes in immunostaining of proliferating cell nuclear antigen (PCNA) in V79 hamster fibroblasts 230
Dosimetric consequences of a translational isocenter correction based on image guidance for intensity modulated radiotherapy (IMRT) of the prostate 230
Direct dose correlation of MRI morphologic alterations of healthy liver tissue after robotic liver SBRT 230
Robustness of sweeping-window arc therapy treatment sequences against intrafractional tumor motion 229
Fast kilovoltage/megavoltage (kVMV) breathhold cone-beam CT for image-guided radiotherapy of lung cancer 227
Experimental validation of a commercial 3D dose verification system for intensity-modulated arc therapies 227
SIS epidemiological model for adaptive RT: Forecasting the parotid glands shrinkage during tomotherapy treatment 227
Critical appraisal of the role of volumetric modulated arc therapy in the radiation therapy management of breast cancer 227
Intra-breath-hold residual motion of image-guided DIBH liver-SBRT: An estimation by ultrasound-based monitoring correlated with diaphragm position in CBCT 227
Conformal radiotherapy of challenging paraspinal tumors using a multiple arc segment technique 226
Optimization of dose distributions for adjuvant loco-regional radiotherapy of gastric cancer by IMRT 225
Should patients with locally advanced, non-metastatic carcinoma of the pancreas be irradiated? 225
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 225
Fiducial-based quantification of prostate tilt using cone beam computer tomography (CBCT) 224
A systematic review and meta-analysis on oncological radiotherapy in patients with a cardiac implantable electronic device: Prevalence and predictors of device malfunction in 3121 patients 222
Impact of gastrointestinal side effects on patients’ reported quality of life trajectories after radiotherapy for prostate cancer: Data from the prospective, observational pros-it CNR study 222
Conventionally fractionated stereotactic radiotherapy (FSRT) for acoustic neuromas 221
Conformal three-dimensional photon radiotherapy for paranasal sinus tumors 220
Totale 26.196
Categoria #
all - tutte 211.828
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 211.828


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.298 0 0 0 258 168 149 265 292 409 371 837 549
2022/20233.998 544 697 368 237 584 431 74 339 441 31 168 84
2023/20242.029 87 137 86 223 416 134 125 388 54 26 67 286
2024/20256.758 278 58 29 394 1.490 1.088 369 349 743 547 585 828
2025/202613.155 531 323 1.217 1.320 1.085 1.164 1.881 858 1.167 1.039 1.353 1.217
2026/20274.374 601 919 1.098 1.756 0 0 0 0 0 0 0 0
Totale 50.188